SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

12.40p
   
  • Change Today:
      0.65p
  • 52 Week High: 29.00
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 211.21m
  • Volume: 2,239,479
  • Market Cap: £26.19m

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2271.3% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 182.7 n/a
Pr/Book 12.1  
Latest F'cast
Revenue 76.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SBTX Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 n/a (1.36) (0.94)p n/a n/a n/a n/a 0.0%
30-Jun-20 n/a (1.62) (1.17)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.50) (0.01)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.07 (2.99) (1.78)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.13 (3.01) (1.72)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SBTX Company Announcements

Closure of Convertible Bond Facility 23-Jul-2024 07:00 RNS
Conversion Notice and Total Voting Rights 22-Jul-2024 07:00 RNS
Notice of Business Update & Investor Presentation 15-Jul-2024 07:00 RNS

SBTX ShareCast News

SkinBioTherapeutics reports positive interim acn... 27-Feb-2024 ShareCast
SkinBioTherapeutics finalises acquisition of Der... 26-Jan-2024 ShareCast
SkinBioTherapeutics launches new consumer study ... 25-Oct-2023 ShareCast

Latest SBTX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

SBTX Market Data

Currency UK Pounds
Share Price 12.40p
Change Today 0.65p
% Change 5.53 %
52 Week High 29.00
52 Week Low 7.25
Volume 2,239,479
Shares Issued 211.21m
Market Cap £26.19m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.4% below the market average70.4% below the market average70.4% below the market average70.4% below the market average70.4% below the market average
80.39% below the sector average80.39% below the sector average80.39% below the sector average80.39% below the sector average80.39% below the sector average
Price Trend
53.58% below the market average53.58% below the market average53.58% below the market average53.58% below the market average53.58% below the market average
19.23% above the sector average19.23% above the sector average19.23% above the sector average19.23% above the sector average19.23% above the sector average
Income Not Available
Growth
22.20% above the market average22.20% above the market average22.20% above the market average22.20% above the market average22.20% above the market average
15.15% above the sector average15.15% above the sector average15.15% above the sector average15.15% above the sector average15.15% above the sector average

SBTX Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
17:05 62,009 @ 12.40p
16:35 81,800 @ 12.40p
16:35 2,217 @ 12.40p
16:35 79,583 @ 12.40p
16:29 10,000 @ 12.30p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page